Sangamo Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Sangamo Biosciences (SGMO) Prices 10M Common Stock Offering at $7.25/Share
June 21, 2017 8:27 AM EDTSangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $7.25 per share. All of the shares are being sold by Sangamo. The gross proceeds to Sangamo from the offering, before... More
